Skip to main content

J&J's consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut

Kenvue's debut is the biggest U.S. IPO since EV maker Rivian went public in 2021.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.